In the latest Vaxart stock price forecast, technical analysts highlight that the 50-day moving average at $0.70 acts as near-term resistance. A breakout could open a path toward $0.85, while failure here may trigger a retracement to $0.62 support. Private equity firms hold a 6.8% stake in Vaxart. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public. I agree to TipRanks Terms of use and Privacy Policy The most recent Vaxart stock price forecast aligns with biotech peer performance. Comparable microcaps in the sector rallied 15% on breakthrough news in April, hinting at upside potential if VXRT delivers trial milestones.